ABSTRACT Background: Proper artificial nutrition for patients who are unable to eat normally is an ongoing, unresolved concern in geriatric medicine and home medical care. Controversy surrounds prognostic differences between parenteral and enteral nutrition, 2 methods for artificial nutrition. Objectives: Short-term outcomes of parenteral and enteral nutrition for patients who are unable to eat normally were compared and analyzed. Design: Data were acquired from patients selected from a national inpatient database covering 1057 hospitals in Japan. Participants had received artificial nutrition between April 2012 and March 2013, were aged $20 y, and did not have cancer. They were separated into 2 groups: those who received parenteral nutrition and those who received enteral nutrition. We performed one-to-one propensity score matching between the groups. The primary outcome measurements were mortality rates at 30 and 90 d after the start of the procedure. The secondary outcomes were postprocedural complications, pneumonia, and sepsis. We analyzed survival length of stay after the procedure with the use of a Cox proportional hazards model. Results: There were 3750 patients in the parenteral group and 22,166 patients in the enteral group. Propensity score matching created 2912 pairs in the 2 groups. Patients with a similar propensity score (probability of being assigned to the enteral group) calculated from the baseline condition were matched. Mortality rates at 30 and 90 d after start of treatment were 7.6% and 5.7% (P = 0.003) and 12.3% and 9.9% (P = 0.002) in the parenteral and enteral groups, respectively. In Cox regression analysis, the HR for the enteral group relative to the parenteral group was 0.62 (95% CI: 0.54, 0.71; P , 0.001). The incidences of postprocedural pneumonia and sepsis were 11.9% and 15.5% (P , 0.001) and 4.4% and 3.7% (P = 0.164) for the parenteral and enteral groups, respectively. Conclusion: The present analysis showed the better survival rate with enteral compared with parenteral nutrition for adults who were not suffering from cancer. This trial was registered at clinicaltrials. gov as NCT02512224.
INTRODUCTION
Artificial nutrition is an option in cases in which patients are unable to eat normally, although the indication for its use is not agreed on. There are 2 options for artificial nutrition: parenteral nutrition, also called intravenous feeding and often achieved by central venous port insertion, and enteral nutrition, in which nourishment is introduced directly into the stomach. Parenteral nutrition is considered to carry risks of catheter infection and suppression of intestinal immunity, and for this reason, enteral nutrition is thought to be superior to parenteral nutrition. The American Society for Parenteral and Enteral Nutrition recommends that enteral nutrition, if feasible, rather than parenteral nutrition should be used (1) . In 2004 and 2010 it was estimated that enteral nutrition was used in at least 145,000 cases in the United States and at least 119,000 cases in Japan (2), respectively.
However, enteral nutrition is not without risks. For example, 2 options for enteral nutrition, percutaneous endoscopic gastrostomy and percutaneous transesophageal gastrotubing, carry a risk of postprocedural aspiration pneumonia caused by gastroesophageal reflux. In addition, low survival rates after percutaneous endoscopic gastrostomy have been reported (2) (3) (4) (5) (6) (7) (8) .
Only a few studies have compared mortality between parenteral and enteral nutrition in patients who need artificial nutrition. Home parenteral nutrition was shown to be a safe substitute for percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis (9) , and there was no difference in mortality between 546 elderly patients that could be attributed to type of artificial nutrition (10) . In fact, there is one study in patients with traumatic brain injury in which patients who received parenteral nutrition had slightly lower mortality than did patients receiving enteral nutrition (11) . These studies are limited, however, by small sample sizes and lack of statistical adjustment for patients' backgrounds. We conclude that, despite the prevailing view, the identification of the safest option for artificial nutrition deserves closer attention.
This study was undertaken to compare short-term outcomes between parenteral and enteral nutrition for patients who are unable to receive oral feeding. We adjusted for patient characteristics and used a national inpatient database in Japan.
METHODS

Setting and participants
For this study, we used the Japanese Diagnosis Procedure Combination database, the details of which were described elsewhere (12) (13) (14) . The database includes administrative claims and discharge abstract data. In 2012, these data were collected for w7 million inpatients from 1057 participating hospitals across Japan, which amounted to approximately half of the acute care hospitalizations in the country. The database includes the following information: unique hospital identifiers; patient's age and sex; main diagnoses, comorbidities on admission, and postadmission complications, both main diagnoses, comorbidities on admission, and postadmission complications are recorded with the International Classification of Diseases, 10th Revision (text data were also recorded in Japanese) (http:// www.dis.h.u-tokyo.ac.jp/byomei/icd10/); procedures coded with original Japanese codes; drugs and devices used; and discharge status. All clinical data for each patient were recorded at discharge by the attending physicians. Physicians are required to record diagnoses consistent with guidelines in published standards, which optimizes accuracy and consistency among them. The dates of hospital admission, discharge, surgery, bedside procedures, and drugs administered were recorded in a uniform format.
All patient identifiers were removed from the database. Study approval was obtained from the Institutional Review Board of the University of Tokyo. Because of the anonymous nature of the data, the board waived the need for informed consent.
We selected patients aged $20 y who had undergone either parenteral nutrition by central venous port insertion or enteral nutrition by percutaneous endoscopic gastrostomy, percutaneous transesophageal gastrotubing, or ileostomy between 1 April 2012 and 31 March 2013. We excluded patients who had been diagnosed with cancer. Patients who received both gastrostomy and central venous port insertion were assigned to the gastrostomy group. Hospital volume was defined as the average annual number of patients who had undergone any of the artificial nutrition methods considered in this study at each hospital.
We identified 28 disease categories, which are listed in Table  1 , accompanied by their codes from the International Classification of Diseases, 10th Revision. The type of disease may, in some cases, have influenced the type of artificial nutrition selected.
The database includes daily information on all the intravenous fluids and enteral nutrients prescribed for each patient. With the use of these data, we calculated the calorie and amino acid intake on the seventh day after the operation. The database includes data for body weight and height on admission for each patient. With the use of these data, we calculated the median (interquartile range) values for body weight and height in each group.
Outcomes
The primary outcomes were defined as the rate of mortality at 14, 30, and 90 d after the start of the procedure. The secondary outcomes included the incidence of postprocedural pneumonia, sepsis occurring during hospitalization, or readmission within 30 d of discharge. For deceased patients, we compared comorbidities on admission and postprocedural complications between groups. 
Statistical analysis
Propensity score matching was used for balancing the baseline characteristics between patients in the parenteral and enteral groups (15) . Propensity score methods are a powerful tool for comparing groups with similar observed characteristics without specifying the relation between confounders and outcomes (13, 14, 16, 17) . First, to determine the propensity score for each patient, logistic regression for predicting the probability that a patient would receive enteral nutrition rather than parenteral nutrition was modeled for the following potential confounders:
age of patient, sex of patient, volume of the patient's hospital, whether the patient had been admitted on an emergency basis, and the underlying disease from the 28 categories. The 28 disease categories consisted of the following: 1) major cause of disabled feeding, 2) diseases that could cause intestinal failure and influence the assignment of enteral or parenteral feeding (i.e., bowel infection, inflammatory bowel disease, ileus, postoperative intestinal problems, gastrointestinal hemorrhage, ischemic intestinal disease, malabsorption, cholelithiasis and cholangitis, pancreatic disease, and chronic liver disease), and 3) other major diseases that may, in some cases, have influenced the type of artificial nutrition selected or prognosis of the patient. A receiver operating curve (ROC) was created to calculate the AUC (C-statistics) to evaluate goodness-of-fit. A one-to-one match with the use of nearest-neighbor matching was performed on the basis of the estimated propensity scores of each patient. A match occurred when one patient in the parenteral group had an estimated score within 0.2 SDs of another in the enteral group (18) . We examined the characteristics of all patients and of propensity-matched patients, and we used the standardized difference to compare the patient characteristics between the parenteral and enteral nutrition groups. The standardized difference compares the difference in means in units of the pooled SD. Each standardized difference was described as a percentage-that is, it was multiplied by 100 to obtain the shown values. The standardized difference for age was calculated from the difference in mean age. An absolute standardized difference .10% indicates a significant imbalance in a covariate (18) (19) (20) (21) (22) (23) .
For comparisons of 14-, 30-, and 90-d mortality rates after the start of the procedure; the 30-d readmission rate; the rate of postprocedural pneumonia; and the rate of postprocedural sepsis, we used chi-square tests between the parenteral and enteral groups in the propensity score-matched groups. Risk differences and their 95% CIs were calculated. In the chi-square test, logrank test, and Cox regression analyses, we did not take into account the matched-pair nature. Instead, in the logistic regression analyses for the propensity score-matched patients, we used generalized estimating equations to account for clustering within propensity score-matched pairs of 2 patients for the parenteral and enteral groups (19, 24, 25) .
We used the Kaplan-Meier method and log-rank test to compare short-term survival between the propensity-matched parenteral and enteral groups. Living discharged patients were regarded as censored cases. We performed a Cox regression analysis to estimate the HRs of death for the enteral nutrition group relative to the parenteral nutrition group. All statistical analyses were conducted by using IBM SPSS, version 22 (IBM SPSS).
RESULTS
Patients were selected from the database according to the criteria outlined above. There were 3750 patients who had received parenteral nutrition and 22,166 patients who had received enteral nutrition. In the enteral nutrition group, 21,665 patients had undergone gastrostomy, 133 patients had undergone percutaneous transesophageal gastrotubing, and 368 patients had undergone ileostomy. Propensity score matching created 2912 pairs in the parenteral and enteral nutrition groups. The AUC of the ROC analysis for goodness-of-fit of the model used for propensity score matching was 0.764 (95% CI: 0.755, 0.773; P , 0.001). The value of 0.764 indicated a fair level of fit. Table 2 shows the baseline characteristics of the unmatched parenteral and enteral groups (n = 25,916) and of the propensity scorematched groups (n = 5824). In the unmatched groups, patients who were elderly, admitted on an emergency basis, or had pneumonia, intracranial injury, cerebrovascular disease, neuromuscular disease, or dementia were more likely to receive enteral nutrition than parenteral nutrition. Patients with the following conditions were more likely to receive parenteral nutrition than enteral nutrition: sepsis on admission, catheter trouble, benign tumor, benign hematologic disease, or gastrointestinal disease including noninfectious inflammatory bowel disease, ileus, postoperative intestinal problems, ischemic intestinal disease, malabsorption, cholelithiasis and cholangitis, pancreatic diseases, and chronic liver disease. After propensity score matching, the absolute standardized differences were all ,10, indicating that the baseline patient characteristics were well balanced between the groups.
The daily calorie and amino acid intake was similar in the 2 groups. In the parenteral and enteral groups, the median (IQR) calorie intake was 840 (410) Table 3 shows the outcomes for the propensity scorematched patients in the parenteral and enteral groups with regard to mortality at 14, 30, and 90 d after the start of the procedure. The incidence of postprocedural pneumonia was 11.9% vs. 15.5% (P , 0.001), whereas the incidence of postprocedural sepsis was 4.4% vs. 3.7% (P = 0.164) for parenteral and enteral groups, respectively. Table 4 shows the results of logistic regression analyses. In comparison with the parenteral group, the OR of mortality at 90 d after the start of the procedure for the enteral group was 0.78 (95% CI: 066, 0.92).
The Kaplan-Meier curve is presented in Figure 1 . The logrank test showed a significant difference between the parenteral and enteral nutrition groups (x 2 = 46.639, P # 0.001). In the Cox regression analysis, the HR for the enteral group relative to the parenteral group was 0.62 (95% CI: 0.54, 0.71; P , 0.001). After excluding patients with gastrointestinal, liver, gallbladder, or pancreatic disease, the subgroup analysis showed results similar to those of the all-patient analysis (Supplemental Table 1 ). Among the deceased patients, approximately half had pneumonia and approximately one-fourth had heart failure on admission (Supplemental Table 2 ). The proportions of urinary tract infection, ileus, or postintestinal operation problems were higher in the enteral group; the proportion of schizophrenia was higher in the parenteral group. With regard to postprocedural complications (Supplemental Table 3 ), the proportions of pneumonia, respiratory failure, and circulatory failure were higher in the enteral group and the proportion of gastrointestinal hemorrhage was higher in the parenteral group.
DISCUSSION
This study compared short-term mortality and morbidity after parenteral or enteral nutrition in adult patients without cancer. It used a large sample from a national inpatient database and a robust analytic approach with propensity score matching to adjust for potential confounding factors. Patients with gastrointestinal diseases were more likely to receive parenteral nutrition, whereas those with neurological diseases were more likely to undergo enteral nutrition. The results showed lower mortality in the enteral than in the parenteral nutrition group.
To improve the comparability of these groups, we excluded patients with cancer because intestinal cancer and intestinal metastasis of various cancers represent one of the largest causes of intestinal failure. We also used propensity score matching to balance the patient backgrounds among the groups. We additionally performed a subgroup analysis excluding gastrointestinal, liver, gallbladder, or pancreatic disease, which showed a better survival rate in the enteral group than in the parenteral group.
The better survival rate with enteral nutrition than with parenteral nutrition is controversial. Previous studies comparing these 2 procedures were limited by small sample sizes. Comparisons may also have been confounded by imbalanced distributions of patient characteristics and, in particular, differences in background diseases, such as gastrointestinal diseases vs. neurological diseases (9) (10) (11) . In this study, we attempted to overcome these limitations by using a large sample size and propensity score-matched pairs. We provide further support for the better survival rate with enteral nutrition than with parenteral nutrition: enteral nutrition was associated with lower short-term mortality than was parenteral nutrition.
The geriatric patients in our Japanese study had relatively low body weights (w44 kg) and had chronic illness with bedridden status. A previous study in geriatric patients showed that their mean resting energy expenditure was 18.8 kcal/kg per day (26) . In the present study, the patients received w20 kcal/kg per day of energy at 7 d postoperatively, which would be sufficient.
The differences reported here may be due to the nutritional and metabolic benefits of the use of the intestine (1) . In a randomized controlled study in patients with ulcerative colitis, patients receiving enteral nutrition had a higher concentration of serum albumin than did those receiving parenteral nutrition (27) . The physiologic use of the intestine may prevent its atrophy and inhibit bacterial translocation, both of which can lead to a chronic inflammation state and promote catabolism (28) (29) (30) . Metabolic advantages, including glycemic control with incretin, nitrogen metabolism, and prevention of liver diseases, may also be associated with enteral nutrition (31) . These factors may have had the synergistic effect of reducing short-term mortality in the enteral group. Sepsis rates did not differ between the enteral and parenteral nutrition groups, whereas the rate of pneumonia was higher in the enteral group than in the parenteral group.
Several prospective randomized controlled trials (PRCTs) related to parenteral and enteral nutrition in an intensive care unit setting were reported recently and produced divergent results (32) (33) (34) (35) (36) (37) (38) ; however, those trials did not compare the outcome of parenteral and enteral nutrition directly. In addition, some metaanalyses of PRCTs comparing parenteral and enteral nutrition in adults found that there were no differences in mortality rate (39) (40) (41) . A recent PRCT that compared parenteral and enteral nutrition in intensive care unit patients did not find any difference in mortality (42) . With respect to the difference in mortality ORs for the enteral group with reference to the parenteral group are shown.
FIGURE 1
Kaplan-Meier analysis of the propensity-matched groups for parenteral and enteral nutrition. Initial numbers of the parenteral and enteral nutrition groups were 2912 each. In the Cox regression analysis, the HR for the enteral group relative to the parenteral group was 0.62 (95% CI: 0.54, 0.71; P , 0.001) found between these previous studies and our study, several reasons may be suggested. First, in the previous studies, the patients were young, critically ill, and nonfrail, which is in contrast to our study, which examined old, frailer patients with chronic diseases. Second, the previous studies were based on combined heterologous subjects derived from small studies; they did not have as much power as our study, with its large sample size, in providing the mortality rate. Third, our study focused mainly on a comparison between the outcomes of gastrostomy, jejunostomy, percutaneous transesophageal gastrotubing, and central venous port insertion in patients who were thought to be incapable of eating over the long term by attending doctors. The benefits of enteral feeding in acute and chronic care are different.
Several PRCTs reported the reduced pulmonary complications in an enteral nutrition group compared with a parenteral nutrition group (43) , which differs from our findings. This difference could be because, unlike previous studies, the present study included older patients. Enteral nutrition carries the risk of gastroesophageal reflux, aspiration, and nosocomial pneumonia, especially in older patients with disordered pharyngeal function (44) (45) (46) (47) (48) (49) (50) (51) (52) .
Several limitations of this study deserve acknowledgment. First, although the study population was large, this investigation was based on a retrospective observational design without randomization. Although a propensity score method was used to adjust for differences in baseline characteristics and severity of conditions, the results may still have been biased by unmeasured confounders, such as the severity of each disease and performance status. The AUC of the ROC analysis for goodness-of-fit of the model used for propensity score matching indicated a fair, but not good, level of fit. This would reflect not only the random aspect of assignment but also the unmeasured confounder of decision making. Second, the database lacked records on vital signs, blood tests, and other graphical tests.
In conclusion, the present propensity-matched analysis with the use of data from a large national database showed a better survival rate with enteral nutrition than with parenteral nutrition in reducing short-term mortality for adults needing artificial nutrition but not afflicted with cancer. Further studies with a PRCT design are required.
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